Kelly T. Dineley, PhDAssociate Professor in the Departments of Neurology,
Neuroscience & Cell Biology, Biochemistry & Molecular Biology, Pharmacology & Toxicology, Center for Addiction Research, Mitchell Center for Neurodegenerative Diseases, Sealy Center on Aging
Director, Rodent In Vivo Assessment Core
Dr. Kelly Dineley attended the University of the Pacific in Stockton, California, where she received her BA in 1983 (Biology) and her MS in 1986 (Cell Biology). In 1998, she received her PhD in Neuroscience from Baylor College of Medicine in Houston, Texas. Following a postdoctoral fellowship in the laboratory of Dr. J David Sweatt, Dr. Dineley joined the faculty ranks at the University of Texas Medical Branch (UTMB) in 2003. She has steadily funded her research with grants from the National Institutes of Health, the John Sealy Memorial Endowment Fund for Biomedical Research, the Dunn Foundation, the Brown Foundation, Inc., the Alzheimer’s Association, the American Health Assistance Foundation, the Peter F. McManus Foundation, and the Mohn Foundation.
Dr. Dineley studies:
- Alzheimer’s disease and Parkinson’s disease and related proteionopathies: amyloidopathies, tauopathies, synucleinopathies
- Cocaine abuse and addiction biology
- Animal models utilizing genetic and pharmacological manipulations
- Omics and bioinformatics approaches for the identification and validation of novel mechanisms that underlie memory and cognitive deficits induced by aging, neurodegenerative disease, and drug abuse
- Nuclear receptors (PPAR), nicotinic acetylcholine receptors, ERK MAPK, CREB, CBP, calcineurin
- Protein-protein interactions
Dr. Dineley lives in Galveston with her husband, Dr. Larry Denner also on faculty at UTMB, and their son, Axel.